SCHEMBL7040394

SCHEMBL7040394

CCCc1c(OCCC[S+]([O-])c2ccc(CC(=O)O)cc2Cl)ccc2c(-c3ccc(F)cc3)noc12

nearest known ligand 0.62

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
PPARD Q03181 19/20 0.62
PPARG P37231 18/20 0.62
PPARA Q07869 17/20 0.62
NR1H2 P55055 5/20 0.59
NR1H3 Q13133 5/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7044955 0.84 PPARD (0.87) PPARDPPARGPPARANR1H2NR1H3
SCHEMBL7042418 0.78 PPARA (0.79) PPARDPPARGPPARA
SCHEMBL7040820 0.77 PPARG (1.00) PPARDPPARGPPARANR1H2NR1H3
SCHEMBL7046131 0.77 PPARG (0.73) PPARDPPARGPPARANR1H2NR1H3
SCHEMBL7044104 0.76 PPARG (0.86) PPARDPPARGPPARANR1H2NR1H3
SCHEMBL8006220 0.76 PPARD (0.71) PPARDPPARGPPARANR1H2NR1H3
SCHEMBL7042295 0.74 PPARA (1.00) PPARDPPARGPPARANR1H2NR1H3
SCHEMBL2896562 0.73 PPARA (1.00) PPARDPPARGPPARA
SCHEMBL7042917 0.73 PPARD (0.73) PPARDPPARGPPARANR1H2NR1H3
SCHEMBL7041507 0.73 PPARG (0.78) PPARDPPARGPPARANR1H2NR1H3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0882029-B1 HETEROCYCLIC DERIVATIVES AS ANTIDIABETIC AND ANTIOBESITY AGENTS MERCK & CO INC (US) 2003-04-02 EP claimed
US-6090836-A DIETETICS; ADJUSTMENT OF TRIGLYCERIDE CONCENTRATION MERCK & CO., INC. (US) 2000-07-18 US claimed
EP-0882029-B1 HETEROCYCLIC DERIVATIVES AS ANTIDIABETIC AND ANTIOBESITY AGENTS MERCK & CO INC (US) 2003-04-02 EP disclosed
US-6090836-A DIETETICS; ADJUSTMENT OF TRIGLYCERIDE CONCENTRATION MERCK & CO., INC. (US) 2000-07-18 US disclosed
EP-0882029-A1 HETEROCYCLIC DERIVATIVES AS ANTIDIABETIC AND ANTIOBESITY AGENTS Merck & Co., Inc. (US) 1998-12-09 EP disclosed
WO-1997028137-A1 HETEROCYCLIC DERIVATIVES AS ANTIDIABETIC AND ANTIOBESITY AGENTS MERCK & CO., INC. (US) 1997-08-07 WO disclosed